88 related articles for article (PubMed ID: 19141566)
21. Targeting IκB kinase β in Adipocyte Lineage Cells for Treatment of Obesity and Metabolic Dysfunctions.
Helsley RN; Sui Y; Park SH; Liu Z; Lee RG; Zhu B; Kern PA; Zhou C
Stem Cells; 2016 Jul; 34(7):1883-95. PubMed ID: 26991836
[TBL] [Abstract][Full Text] [Related]
22. RFamide neuropeptides inhibit murine and human adipose differentiation.
Herrera-Herrera ML; Salazar-Olivo LA
Biochem Biophys Res Commun; 2008 Dec; 377(1):29-34. PubMed ID: 18823948
[TBL] [Abstract][Full Text] [Related]
23. Impact of stimulatory pathways on adipogenesis and HIV-therapy associated lipoatrophy.
Stankov MV; Schmidt RE; Behrens GM
Exp Biol Med (Maywood); 2009 Dec; 234(12):1484-92. PubMed ID: 19934369
[TBL] [Abstract][Full Text] [Related]
24. TSH signaling pathways that regulate MCP-1 in human differentiated adipocytes.
Gagnon A; Langille ML; Chaker S; Antunes TT; Durand J; Sorisky A
Metabolism; 2014 Jun; 63(6):812-21. PubMed ID: 24661543
[TBL] [Abstract][Full Text] [Related]
25. Enhanced effects of guggulsterone plus 1,25(OH)2D3 on 3T3-L1 adipocytes.
Rayalam S; Della-Fera MA; Ambati S; Boyan B; Baile CA
Biochem Biophys Res Commun; 2007 Dec; 364(3):450-6. PubMed ID: 17959142
[TBL] [Abstract][Full Text] [Related]
26. Anti-adipogenic effect of PDGF is reversed by PKC inhibition.
Artemenko Y; Gagnon A; Aubin D; Sorisky A
J Cell Physiol; 2005 Aug; 204(2):646-53. PubMed ID: 15754337
[TBL] [Abstract][Full Text] [Related]
27. The tyrosine kinase receptor HER2 (erbB-2): from oncogenesis to adipogenesis.
Vazquez-Martin A; Ortega-Delgado FJ; Fernandez-Real JM; Menendez JA
J Cell Biochem; 2008 Dec; 105(5):1147-52. PubMed ID: 18814184
[TBL] [Abstract][Full Text] [Related]
28. Adipogenic action of vanadium: a new dimension in treating diabetes.
Shukla R; Bhonde RR
Biometals; 2008 Apr; 21(2):205-10. PubMed ID: 17671828
[TBL] [Abstract][Full Text] [Related]
29. Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3'-kinase.
Pereira RI; Leitner JW; Erickson C; Draznin B
Life Sci; 2008 Nov; 83(19-20):638-43. PubMed ID: 18824177
[TBL] [Abstract][Full Text] [Related]
30. (-)-Ternatin inhibits adipogenesis and lipid metabolism in 3T3-L1 cells.
Ito M; Ito J; Kitazawa H; Shimamura K; Fukami T; Tokita S; Shimokawa K; Yamada K; Kanatani A; Uemura D
Peptides; 2009 Jun; 30(6):1074-81. PubMed ID: 19463739
[TBL] [Abstract][Full Text] [Related]
31. SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia.
Lu DY; Tang CH; Yeh WL; Wong KL; Lin CP; Chen YH; Lai CH; Chen YF; Leung YM; Fu WM
Eur J Pharmacol; 2009 Jun; 613(1-3):146-54. PubMed ID: 19285061
[TBL] [Abstract][Full Text] [Related]
32. Effect of insulin detemir, compared to human insulin, on 3T3-L1 adipogenesis.
Böhm A; Staiger H; Hennige AM; Haas C; Machicao F; Häring HU
Regul Pept; 2008 Nov; 151(1-3):160-3. PubMed ID: 18571747
[TBL] [Abstract][Full Text] [Related]
33. Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots.
Tchkonia T; Tchoukalova YD; Giorgadze N; Pirtskhalava T; Karagiannides I; Forse RA; Koo A; Stevenson M; Chinnappan D; Cartwright A; Jensen MD; Kirkland JL
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E267-77. PubMed ID: 15383371
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of new flavonoid fatty acid esters with anti-adipogenic and enhancing glucose consumption activities.
Zhao W; Sun J; Xiang H; Zeng YY; Li XB; Xiao H; Chen DY; Ma RL
Bioorg Med Chem; 2011 May; 19(10):3192-203. PubMed ID: 21515060
[TBL] [Abstract][Full Text] [Related]
35. TNFalpha is a potent inducer of platelet-activating factor synthesis in adipocytes but not in preadipocytes. Differential regulation by PI3K.
Gountopoulou A; Leondaritis G; Galanopoulou D; Mavri-Vavayanni M
Cytokine; 2008 Feb; 41(2):174-81. PubMed ID: 18180165
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes.
Berggreen C; Gormand A; Omar B; Degerman E; Göransson O
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E635-46. PubMed ID: 19158325
[TBL] [Abstract][Full Text] [Related]
37. Increase of adipogenesis by ginsenoside (Rh2) in 3T3-L1 cell via an activation of glucocorticoid receptor.
Niu CS; Yeh CH; Yeh MF; Cheng JT
Horm Metab Res; 2009 Apr; 41(4):271-6. PubMed ID: 19048455
[TBL] [Abstract][Full Text] [Related]
38. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
39. Regulation of adipocyte differentiation by histone deacetylase inhibitors.
Kim SN; Choi HY; Kim YK
Arch Pharm Res; 2009 Apr; 32(4):535-41. PubMed ID: 19407971
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes.
Widberg CH; Newell FS; Bachmann AW; Ramnoruth SN; Spelta MC; Whitehead JP; Hutley LJ; Prins JB
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E121-31. PubMed ID: 18940940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
